- Investing Ideas
- Swiss Healthcare Undervalued over 20% based on DCF
Swiss Healthcare Undervalued over 20% based on DCF
Results
6
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
6 companies
Alcon
Market Cap: CHF 27.8b
Researches, develops, manufactures, distributes, and sells eye care products worldwide.
ALC
CHF 56.94
7D
5.4%
1Y
-18.3%
Straumann Holding
Market Cap: CHF 16.0b
Provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally.
STMN
CHF 100.15
7D
-3.4%
1Y
-4.5%
Sonova Holding
Market Cap: CHF 12.3b
Manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
SOON
CHF 207.20
7D
2.5%
1Y
-9.9%
Galenica
Market Cap: CHF 4.4b
Provides healthcare services in Switzerland and internationally.
GALE
CHF 88.45
7D
1.7%
1Y
-1.0%
medmix
Market Cap: CHF 341.2m
Designs, produces, and sells high-precision devices and services in Switzerland and internationally.
MEDX
CHF 8.39
7D
4.5%
1Y
-32.3%
COLTENE Holding
Market Cap: CHF 316.1m
Develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania.
CLTN
CHF 52.90
7D
4.3%
1Y
-22.5%